The above results strongly suggested that up-regulation of MIAT in the setting of MI could dramatically reduce the availability of functional miR-24 in the heart, or more specifically in CFs. The gene discussed is MIAT; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.